MEDSIR-LED CLINICAL TRIALS UNITE SCIENTIFIC EXCELLENCE, PATIENT FOCUS AND STRATEGIC THINKING. MEDSIR MANAGEMENT MODEL ENSURES SPEED, RELIABILITY AND THE STREAMLINING OF CLINICAL DEVELOPMENT PLANS.
SMART STUDY DESIGNS FOR STRATEGIC CLINICAL TRIALS
WE STRIVE TO IMPROVE THE LIVES OF ALL PATIENTS WITH CANCER
The MEDSIR concept of providing a platform to facilitate the development of ideas into strategic clinical study protocols is becoming more diverse, incorporating not only new tumor types, but also modern and innovative trial designs such as umbrella and multi-tumor basket trials.
Working on a new clinical project with the expectation that it will help many patients is exhilarating for MEDSIR, a job well done means results that have the potential to change clinical practice. Here you will find our comprehensive project portfolio.
Please contact us for further information.
“LET´S CONVERT YOUR RESEARCH IDEA INTO A BRIGHTER FUTURE FOR CANCER PATIENTS”
MEDSIR'S CLINICAL STUDIES
Neoadjuvant therapy with weekly (1) paclitaxel and neratinib, or (2) trastuzumab and paclitaxel, or (3) neratinib, trastuzumab, and paclitaxel, followed by doxorubicin and cyclophosphamide for postoperative locally...
Optimization of balixafortide with nab-paclitaxel or eribulin for HER2- advanced breast cancer
THE ULTIMATE GOAL OF MEDSIR PROJECTS IS THE PUBLICATION OF ITS STUDY RESULTS, WHETHER IN PEER-REVIEWED JOURNALS OR AT A NUMBER OF NATIONAL AND INTERNATIONAL CONFERENCES IN THE FORM OF ABSTRACTS, POSTERS, OR ORAL PRESENTATIONS.
ABSTRACT (Posters, presentations, etc.)
Other MEDSIR related articles